Pharmaceuticals, Biotechnology and Life Sciences
Boys and Girls Clubs of Canada (BGCC) has partnered with NARCAN Nasal Spray manufacturers, Adapt Pharma Canada, in the continued fight against the devastating fallout of Canada’s opioid crisis.
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
Johnson & Johnson’s Janssen has welcomed the news from Health Canada as it got approval to use Zytiga combined with prednisone…
Orexigen Therapeutics said that Health Canada has accepted to review a New Drug Submission for marketing approval of its products Contrave (naltrexone HCl and bupropion HCl).
Invictus MD Strategies Corp.,Canada’s cannabis company, said Thursday it will move its shares from the Canadian Securities Exchange and be listed on TSX Venture Exchange, where it starts trading on March 31, 2017.
Canadian commercial dermatology company Crescita Therapeutics has named its Corporate Controller Ms. Muneerah Kanji as Interim Chief Financial Officer.
Sanofi announced on Wednesday two approvals for its drugs in North America. Rheumatoid arthritis drug, which it has made in cooperation with Regeneron Pharmaceuticals, has been approved by Health Canada and the U.S. Food and Drug Administration (FDA) has approved Xyzal Allergy 24HR
As deaths from powerful painkillers continue to rise, Canada is pursuing unprecedented measures to curb their use, including requiring cigarette-style warning stickers on every prescription, Health Minister Jane Philpott told Reuters.
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
Exelixis and Ipsen have signed an amendment to the exclusive collaboration and licensing agreement for the commercialization and continued development…